NCT05266404 Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components Status COMPLETED Phase PHASE1
NCT05262257 Evaluation and Intervention of Cognitive Function in Patients With Diabetes Mellitus. Status UNKNOWN Phase EARLY_PHASE1
NCT05250011 Observation of Italian Patients With Heart Failure Being Treated With Dapagliflozin in Clinical Practice Status COMPLETED Phase N/A
NCT05196347 Dapagliflozin and Renal Surrogate Outcomes in Advanced Chronic Kidney Disease Status COMPLETED Phase PHASE3
NCT05194592 Comparison of the Effects of Dapagliflozin and Gemigliptin on Ketone Metabolism and Cardiac Remodeling in Type 2 Diabetes Status UNKNOWN Phase PHASE4
NCT05139914 Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes Status TERMINATED Phase PHASE4
NCT05058859 Long Term Clinical Efficacy of Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor in Cystinurics Status WITHDRAWN Phase PHASE2
NCT04956263 A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE2
NCT04899349 Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant Status TERMINATED Phase PHASE2
NCT04882813 Replication of the DAPA-CKD (Chronic Kidney Disease) Trial in Healthcare Claims Data Status COMPLETED Phase N/A
NCT04856969 Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT04818034 The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary Study Status COMPLETED Phase PHASE2
NCT04796428 GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial Status UNKNOWN Phase PHASE4
NCT04792190 Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation Status COMPLETED Phase PHASE4
NCT04780438 Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation. Status UNKNOWN Phase EARLY_PHASE1
NCT04764097 Dapagliflozin Effect on Cardiovascular Outcomes in Haemodialysis for End Stage Renal Disease Status WITHDRAWN Phase PHASE2/PHASE3